No insider purchase over the last 90 days. The latest, by Vasant Rathi, was filed 11 Mar 2026.
Advanced Enzyme Technologies Limited is a Technology company. Its directors and officers file their transactions with SEBI (PIT + SAST). From 24 October 2025 to 24 October 2026, the disclosure feed for Advanced Enzyme Technologies Limited logged 13 filings by 6 insiders.
Not one open-market sale was filed. On the buying side, 1 insider reported 8 purchases totalling €679k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The largest single trade was a purchase of €178k by Vasant Rathi, published on 10 March 2026, equal to 0.056% of the market capitalisation. Those buying include 1 major shareholder.
With 13 filings in twelve months, the company is more active than the median of 4 filings across the 1,987 companies we follow on the same exchange. Our records for Advanced Enzyme Technologies Limited go back to 2021, with 30 purchases and 110 sales on the open market in total.
The clock since the last published purchase (11 March 2026) now reads 227 days. Typically, a trade is published a median of 1 day after it takes place. The shorter that gap, the sooner other investors can see what insiders have done.
Elsewhere in the same sector, our signals recently picked up insider purchases at Core Scientific, Inc./tx and Gitlab Inc. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended March 2026 · cache
25 of 164 declarations
Advanced Enzyme Technologies Limited is a company focused on the development and manufacturing of enzymes for various industrial applications. It primarily operates in the Indian market and emphasizes innovation in the biotechnology sector.
Purchases our model currently ranks for the recommendations list.
All recommendations